| 000 | 01836 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514054928.0 | ||
| 264 | 0 | _c20030410 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a1071-9164 | ||
| 024 | 7 |
_a10.1054/jcaf.2002.129233 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathier, Michael A | |
| 245 | 0 | 0 |
_aExaggerated cardiovascular effects of cocaine in conscious dogs with pacing-induced dilated cardiomyopathy. _h[electronic resource] |
| 260 |
_bJournal of cardiac failure _cDec 2002 |
||
| 300 |
_a407-15 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBaroreflex _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiac Pacing, Artificial _xadverse effects |
| 650 | 0 | 4 |
_aCardiomyopathy, Dilated _xblood |
| 650 | 0 | 4 |
_aCardiovascular System _xdrug effects |
| 650 | 0 | 4 |
_aCocaine _xpharmacology |
| 650 | 0 | 4 | _aDenervation |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDobutamine _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Cardiovascular |
| 650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
| 650 | 0 | 4 |
_aNorepinephrine _xblood |
| 650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
| 650 | 0 | 4 |
_aPressoreceptors _xdrug effects |
| 650 | 0 | 4 |
_aSinoatrial Node _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aShen, You-Tang | |
| 700 | 1 | _aShannon, Richard P | |
| 773 | 0 |
_tJournal of cardiac failure _gvol. 8 _gno. 6 _gp. 407-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1054/jcaf.2002.129233 _zAvailable from publisher's website |
| 999 |
_c12330399 _d12330399 |
||